Henry Schein 2003 Annual Report Download - page 19

Download and view the complete annual report

Please find page 19 of the 2003 Henry Schein annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 64

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64

Years ended
December 27, December 28, December 29, December 30, December 25,
2003 2002 2001 2000 1999
(In thousands, except selected operating data)
Selected Operating Data
(unaudited):
Number of orders shipped 8,825,000 7,861,000 7,891,000 8,280,000 7,979,000
Average order size $ 380 $ 359 $ 324 $ 288 $ 286
Net Sales by Market Data:
Healthcare distribution (3):
Dental (4) $1,364,812 $1,227,273 $1,121,394 $1,087,073 $1,056,406
Medical (5) 1,338,084 1,093,956 982,569 851,301 767,258
International (6) 576,628 437,046 398,071 389,946 403,140
Total healthcare distribution 3,279,524 2,758,275 2,502,034 2,328,320 2,226,804
Technology (7) 74,281 66,726 56,209 53,401 57,740
Total $3,353,805 $2,825,001 $2,558,243 $2,381,721 $2,284,544
Balance Sheet Data:
Total assets $1,819,370 $1,558,052 $1,385,428 $1,231,068 $1,204,102
Long-term debt 247,100 242,561 242,169 266,224 318,218
Minority interest 11,532 6,748 6,786 7,996 7,855
Stockholders' equity 1,004,118 861,217 680,457 579,060 517,867
(1) In 2002, we revised our original estimates of our anticipated merger, integration and restructuring costs. This change in estimates is
attributable to facts and circumstances that arose subsequent to the original charges. As a result, we recorded additional expenses
and reversed certain of our previously recorded expenses. Merger, integration and restructuring costs consisted primarily of
investment banking, legal, accounting and advisory fees, severance costs and benefits, facility costs, write-offs of duplicate
management information systems and other assets.
(2) In the third quarter of 2003, we sold PMA Bode GmbH, an x-ray film distribution business located in Germany, which was a component
of our healthcare distribution business. Due to immateriality, we have not reflected the operating results of PMA Bode separately as
a discontinued operation for any of the periods presented.
(3) Consists of consumable products, small equipment, laboratory products, large dental equipment, branded and generic
pharmaceuticals, surgical products, diagnostic tests, infection control products and vitamins.
(4) Consists of products sold in the United States and Canada.
(5) Consists of products sold in the United States’ Medical and Veterinary markets.
(6) Consists of products sold in the Dental, Medical and Veterinary markets, primarily in Europe.
(7) Consists of practice management software and other value-added products and services, which are sold primarily to healthcare
professionals in the United States and Canada.
17